BioPharmaDevice

Brought to you by Content Carnivores

[BioPharmaDevice @OneMedWorld]

$GOVX working on addressing the shortage of available #MPOX vaccine. Update from CEO on the disease and the growing need here. https://t.co/O0ZhYSKdlH

[BioPharmaDevice @OneMedWorld]

Just Released: 17-page Research Update on biotech company, GeoVax Labs, Inc. (GOVX-NASDAQ) with multiple trials advancing. https://t.co/n8eery0CHO

[BioPharmaDevice @OneMedWorld]

Bundling Boomer Housing with On-site Primary Care and Wellness-Focused Living: It Just Makes Sense #healthcare #feedly https://t.co/0sNPCTGIhS

[BioPharmaDevice @OneMedWorld]

The One Thing Everyone Should Know About Fall COVID Vaccines #immunocompromised #feedly https://t.co/yRgj1iW7Vn

[B2i Digital @b2idigital]

We want to welcome @Geovax_News to the @ROTHCapital Partners 3rd Annual Healthcare Opportunities Conference October 9th. See their profile on @B2iDigital at https://t.co/5MsVsQ9rvX

GeoVax Labs, Inc. is a clinical-stage biotechnology company developing vaccines and immunotherapies against infectious diseases and cancers using novel proprietary platforms. GeoVax’s product pipeline includes ongoing human clinical trials for a next-generation COVID-19 vaccine and therapy for advanced head and neck cancer. Additional development programs include preventive vaccines against Mpox and smallpox, hemorrhagic fever viruses (Ebola Zaire, Ebola Sudan, and Marburg), malaria and Zika virus, as well as therapies for various solid tumors. (Source: Company Website 08.06.24)

We look forward to seeing the continued results from David A. Dodd, Arban Domi, Mary Hauser, Susan Hensley, MS, RAC, Kelly McKee, Mark Newman, John Niles, Tom O'Brien, Sreenivasa Rao Oruganti, J. Marc Pipas, MD, Erica Raiden, Mark Reynolds, John W. Sharkey, Jeff Welch, Ashley Zuniga, PhD PMP and the entire GeoVax Labs, Inc. team!

Thanks to the stellar team at ROTH for organizing this conference: Sagar Sheth, Byron Roth, Isabel Mattson-Pain, Amanda McAdams, Otilia "Charo" Montano, Benjamin Bowen, James Antonopoulos, Jason Wittes, Jonathan Aschoff, Ph.D., Boobalan Pachaiyappan, Ph.D. and many others

ROTH is a relationship-driven investment bank headquartered in Newport Beach, CA. For more information on ROTH, please visit https://t.co/f7LaejqxRB.

We hope you’ll be able to attend this pivotal event shaping the future of healthcare innovation.

[PC28 百家乐 拳击 返水 真人 申博体育 美博电子 开元 VR棋牌 @HealthierIT]

Stand Up for Insulin Choice at the Congressional Hearing! https://t.co/YsOEBRkKwH @SenSanders @PattyMurray @SenBobCasey @SenatorBaldwin @ChrisMurphyCT @timkaine @SenatorHassan @SenTinaSmith @SenatorLujan @SenatorHick @SenMarkey @SenBillCassidy @SenatorCollins

[BioPharmaDevice @OneMedWorld]

Here are some great reasons why some insulin works for some, and not for others. #contingencyplans

[PC28 百家乐 拳击 返水 真人 申博体育 美博电子 开元 VR棋牌 @HealthierIT]

Why Insulin Choice Matters…https://t.co/MtlndCZ2Tr @InsulinChoice @SenSanders @PattyMurray @SenBobCasey @SenatorBaldwin @ChrisMurphyCT @timkaine @SenatorHassan @SenTinaSmith @SenatorLujan @SenatorHick @SenMarkey @SenBillCassidy @SenatorCollins @lisamurkowski @SenatorBraun

[BioPharmaDevice @OneMedWorld]

So this is really important - contingency plans for discontinued drugs, devices and diagnostics...there is no one size fits all in healthcare! #insulin

[About Medtech @AboutMedtech]

Contact Your Senator to Protect Insulin Choices! https://t.co/HMJVin3zqv @InsulinChoice @SenSanders @SenatorBraun @RogerMarshallMD @SenatorRomney @SenMullin @SenTedBuddNC

[BioPharmaDevice @OneMedWorld]

Contact your representatives today to demand action at a patient contingency plan. https://t.co/1VhrJyBE5s @InsulinChoice @SenSanders @SenBobCasey @SenatorBaldwin @SenatorHick @SenMarkey @SenBillCassidy @SenatorCollins @lisamurkowski @RogerMarshallMD @SenatorRomney #insulin

[BioPharmaDevice @OneMedWorld]

#mpox https://t.co/HvsnRsZZUp

[BioPharmaDevice @OneMedWorld]

Registration Is Now Open for Tribe Public’s Webinar Event
"Now Is Not the Time to Monkey(pox) Around" Featuring GeoVax Lab’s CEO. https://t.co/V9KC6IDCP9 #mpox #vaccine $GOVX

[BioPharmaDevice @OneMedWorld]

Have a question about the state of an #Mpoxvaccine ? $GOVX GeoVax Labs to Present at the Emerging Growth Conference on August 21, 2024
[email protected]

[BioPharmaDevice @OneMedWorld]

https://t.co/GWS8z6lrXC

[BioPharmaDevice @OneMedWorld]

GeoVax Shares Are Making Big Moves: What's Going On? https://t.co/voh9CjUVZJ

[Morehouse School of Medicine @MSMEDU]

#ICYMI: MSM has received a generous commitment of $175 million from @MikeBloomberg and @BloombergDotOrg to support our endowment! 🌟

This gift will further our mission of leading the creation and advancement of health equity. 🩺

Learn more: https://t.co/cIJPcAx2S2

[BioUtah @BioUtah]

Venture Capital Podcast revealed its Founder 100 list for Utah! BioUtah members that made the list include:

• David Bearss – Halia Therapeutics
• Chiao-ih Hui, Solution Diagnostics
• Mark Newman – Nomi Health
• Kurt Workman – Owlet

https://t.co/95wcOg13WU

[GeoVax, Inc. @Geovax_News]

$350 Million, 10,000-participant randomized Phase 2b study will evaluate and compare GeoVax’s multi-antigen, vaccine candidate (GEO-CM04S1) to an approved vaccine against COVID-19 under BARDA’s Clinical Studies Network. https://t.co/zxe3NnlXRl

[Morehouse School of Medicine @MSMEDU]

Dr. Valerie Montgomery Rice (@MSMPres) celebrates @Geovax_News 's $350M+ federal grant for a next-gen COVID-19 vaccine, highlighting its potential to enhance health equity.

Read more: https://t.co/97dXZZ2f5d

#HealthEquity #MorehouseSchoolofMedicine #COVID19